0001209191-20-020355.txt : 20200319
0001209191-20-020355.hdr.sgml : 20200319
20200319200015
ACCESSION NUMBER: 0001209191-20-020355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200317
FILED AS OF DATE: 20200319
DATE AS OF CHANGE: 20200319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Enyedy Mark J
CENTRAL INDEX KEY: 0001586965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38707
FILM NUMBER: 20729931
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664106
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471514975
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-245-0399
MAIL ADDRESS:
STREET 1: 99 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-17
0
0001664106
LogicBio Therapeutics, Inc.
LOGC
0001586965
Enyedy Mark J
99 ERIE STREET
SUITE B
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
5.34
2020-03-17
4
A
0
20000
0.00
A
2030-03-17
Common Stock
20000
20000
D
The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, March 17, 2020.
/s/ Jonathan Quick, as Attorney-in-Fact
2020-03-19